Clinique Pasteur   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Toulouse France (1954)

Organization Overview

First Clinical Trial
2010
NCT01237483
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Clinique Pasteur | Clinique Pasteur, 31300 Toulouse, France | Clinique Pasteur - Brest | Clinique Pasteur, Brest | Clinique Pasteur, Toulouse | Dr Vincent Misrai

Active Ingredients

Drugs in Phase 3 Trials (1)

cabazitaxel (jevtana kit) (1 trial)

Drugs in Phase 2 Trials (1)

cetuximab (erbitux) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 3)

Head and Neck Neoplasms (Phase 2)

Prostatic Neoplasms (Phase 3)

Recurrence (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2